TipRanks
Go Ultimate55% OFF

Anthony M. Manning Insider Profile

4 Followers

Anthony M. Manning, Director at Monte Rosa Therapeutics, holds 0.00 shares in Monte Rosa Therapeutics (Ticker: GLUE), holds 36.08K shares in Palatin Technologies (Ticker: PTN), holds 0.00 shares in Momenta Pharma (Ticker: MNTA).

Anthony M. Manning's Trading History

GLUE
Monte Rosa Therapeutics
Jun 30, 2026DirectorUninformative Buy41.60K$0.00
PTN
Palatin Technologies
Jul 16, 2024DirectorUninformative Buy―$180.40K
MNTA
Momenta Pharma
Oct 01, 2020―Uninformative Sell―$0.00

You May Also Like

Anthony M. Manning insider profile FAQ

What is the percentage of profitable transactions made by Anthony M. Manning?
The percentage of profitable transactions made by Anthony M. Manning is 100%.
What is the average return per transaction made by Anthony M. Manning?
The average return per transaction made by Anthony M. Manning is 49.10%.
What stocks does Anthony M. Manning hold?
Anthony M. Manning holds: GLUE, MNTA, PTN stocks.
What was Anthony M. Manning’s latest transaction?
Anthony M. Manning’s latest transaction was an Uninformative Buy of $41.60K.
What was Anthony M. Manning's most profitable transaction?
Anthony M. Manning’s most profitable transaction was an Informative Sell of GLUE stock on June 30, 2026. The return on the trade was 55.50%.
What is Anthony M. Manning's role in Monte Rosa Therapeutics?
Anthony M. Manning's role in Monte Rosa Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.